Newcastle University Study Could Lead To Approval Of Test For Bladder Cancer
Ethical approval to undertake a six month clinical study has been announced by Arquer Diagnostics Ltd for its ELISA-based urine test for cancer. A Health Research Authority Research Ethics Committee (REC) has approved the project’s Protocol and the new study will provide the data necessary for regulatory approval and registration of the company’s Mcm5-ELISA test for the diagnosis of bladder cancer.